Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208485557> ?p ?o ?g. }
- W3208485557 endingPage "4909" @default.
- W3208485557 startingPage "4909" @default.
- W3208485557 abstract "Prostate-specific membrane antigen (PSMA) is not sufficiently overexpressed in a small proportion of prostate cancer (PCa) patients, who require other strategies for imaging and/or treatment. We reviewed potential targets other than PSMA for PCa theranostics in nuclear medicine that have already been tested in humans.We performed a systematic web search in the PubMed and Cochrane databases, with no time restrictions by pooling terms (prostate cancer, prostatic neoplasms) and (radioligand, radiotracer). Included articles were clinical studies. The results were synthetized by the target type.We included 38 studies on six different targets: gastrin-releasing peptide receptors (GRPRs) (n = 23), androgen receptor (n = 11), somatostatin receptors (n = 6), urokinase plasminogen activator surface receptor (n = 4), fibroblast activation protein (n = 2 studies) and integrin receptors (n = 1). GRPRs, the most studied target, has a lower expression in high-grade PCa, CRPC and bone metastases. Its use might be of higher interest in treating earlier stages of PCa or low-grade PCa. Radiolabeled fibroblast activation protein inhibitors were the most recent and promising molecules, but specific studies reporting their interest in PCa are needed.Theranostics in nuclear medicine will continue to develop in the future, especially for PCa patients. Targets other than PSMA exist and deserve to be promoted." @default.
- W3208485557 created "2021-11-08" @default.
- W3208485557 creator A5003543526 @default.
- W3208485557 creator A5023740879 @default.
- W3208485557 creator A5026135868 @default.
- W3208485557 creator A5028242882 @default.
- W3208485557 creator A5034888525 @default.
- W3208485557 creator A5040219451 @default.
- W3208485557 creator A5054669965 @default.
- W3208485557 creator A5061777389 @default.
- W3208485557 creator A5064914239 @default.
- W3208485557 creator A5068223483 @default.
- W3208485557 creator A5076511947 @default.
- W3208485557 creator A5078599853 @default.
- W3208485557 creator A5079922637 @default.
- W3208485557 creator A5083047631 @default.
- W3208485557 creator A5088072625 @default.
- W3208485557 date "2021-10-24" @default.
- W3208485557 modified "2023-10-08" @default.
- W3208485557 title "Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review" @default.
- W3208485557 cites W1554150286 @default.
- W3208485557 cites W15900271 @default.
- W3208485557 cites W1966952526 @default.
- W3208485557 cites W1968170734 @default.
- W3208485557 cites W1975450774 @default.
- W3208485557 cites W1994793426 @default.
- W3208485557 cites W2018893163 @default.
- W3208485557 cites W2020804208 @default.
- W3208485557 cites W2028726843 @default.
- W3208485557 cites W2038676096 @default.
- W3208485557 cites W2050551827 @default.
- W3208485557 cites W2065571239 @default.
- W3208485557 cites W2085562053 @default.
- W3208485557 cites W2095531714 @default.
- W3208485557 cites W2100550345 @default.
- W3208485557 cites W2101301092 @default.
- W3208485557 cites W2112113117 @default.
- W3208485557 cites W2114562672 @default.
- W3208485557 cites W2116232233 @default.
- W3208485557 cites W2131717149 @default.
- W3208485557 cites W2131970757 @default.
- W3208485557 cites W2144240397 @default.
- W3208485557 cites W2183255199 @default.
- W3208485557 cites W2301515918 @default.
- W3208485557 cites W2339733785 @default.
- W3208485557 cites W2395057684 @default.
- W3208485557 cites W2395284164 @default.
- W3208485557 cites W2476760949 @default.
- W3208485557 cites W2504946646 @default.
- W3208485557 cites W2509443759 @default.
- W3208485557 cites W2537804190 @default.
- W3208485557 cites W2596023559 @default.
- W3208485557 cites W2605392160 @default.
- W3208485557 cites W2608461130 @default.
- W3208485557 cites W2765188120 @default.
- W3208485557 cites W2767214731 @default.
- W3208485557 cites W2767407125 @default.
- W3208485557 cites W2771847508 @default.
- W3208485557 cites W2796034875 @default.
- W3208485557 cites W2887241162 @default.
- W3208485557 cites W2894536640 @default.
- W3208485557 cites W2901801424 @default.
- W3208485557 cites W2904765103 @default.
- W3208485557 cites W2909064569 @default.
- W3208485557 cites W2914433591 @default.
- W3208485557 cites W2921565157 @default.
- W3208485557 cites W2930582547 @default.
- W3208485557 cites W2966069583 @default.
- W3208485557 cites W2969597454 @default.
- W3208485557 cites W2971610733 @default.
- W3208485557 cites W2981515204 @default.
- W3208485557 cites W2999417355 @default.
- W3208485557 cites W3034536516 @default.
- W3208485557 cites W3037430922 @default.
- W3208485557 cites W3048050503 @default.
- W3208485557 cites W3124546863 @default.
- W3208485557 cites W3128776538 @default.
- W3208485557 cites W3133544451 @default.
- W3208485557 cites W3140933759 @default.
- W3208485557 cites W3150050253 @default.
- W3208485557 cites W3161392577 @default.
- W3208485557 cites W3168527111 @default.
- W3208485557 cites W3173923097 @default.
- W3208485557 cites W3176208875 @default.
- W3208485557 cites W3180431563 @default.
- W3208485557 doi "https://doi.org/10.3390/jcm10214909" @default.
- W3208485557 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8584491" @default.
- W3208485557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34768432" @default.
- W3208485557 hasPublicationYear "2021" @default.
- W3208485557 type Work @default.
- W3208485557 sameAs 3208485557 @default.
- W3208485557 citedByCount "3" @default.
- W3208485557 countsByYear W32084855572022 @default.
- W3208485557 countsByYear W32084855572023 @default.
- W3208485557 crossrefType "journal-article" @default.
- W3208485557 hasAuthorship W3208485557A5003543526 @default.
- W3208485557 hasAuthorship W3208485557A5023740879 @default.
- W3208485557 hasAuthorship W3208485557A5026135868 @default.